Article Details
Retrieved on: 2022-05-18 21:02:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
WESTMINSTER — After nearly doubling its year-over-year losses in 2021, Arca Biopharma Inc.'s (Nasdaq: ABIO) board of directors has established a ...
Article found on: bizwest.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here